Scientia Vascular Announces $14 Million Growth Financing Led by Piper Sandler Merchant Banking
Summary
WEST VALLEY CITY, Utah, Sept. 9, 2024 /PRNewswire/ -- Scientia Vascular, a leader in neurovascular innovation, is pleased to announce the closing of a $14 million growth financing led by Piper Sandler Merchant Banking. As Scientia moves ahead, microfabrication will continue to serve as the platform for innovating technologies that address a wide array of neurovascular disease states more effectively.Tom Schnettler, managing director at Piper Sandler Merchant Banking, said, "Scientia exemplifies many of the attributes we look for in an investment partner: a strong team with a long track record of innovation and success, differentiated and groundbreaking technology that improves patient outcomes, a large and growing market opportunity and strong financial performance. We look forward to partnering with John Lippert and the rest of the team at Scientia to support the next stage of the companys growth. We are grateful for the support of Piper Sandler Merchant Banking as we look to accelerate our growth following the launch of our Plato 17 and Socrates 38 neurovascular catheters," said John Lippert, founder and CEO of Scientia.Scientia Vascular is committed to enhancing patient care through innovative medical devices. The PSMB team strives to partner with founders and CEOs of growing, commercial stage businesses that can benefit by leveraging Piper Sandlers knowledge, experience, capital and relationships to build market leading enterprises.